# MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity

> **NCT01313767** · PHASE3 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 196 (actual)

## Conditions studied

- Spasticity

## Interventions

- **DRUG:** Botulinum toxin type A
- **DRUG:** Botulinum Toxin type A

## Key facts

- **NCT ID:** NCT01313767
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-01
- **Final completion:** 2012-02
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2019-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313767, "MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01313767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*